These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8971966)

  • 21. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches.
    Delforge J; Syrota A; Bottlaender M; Varastet M; Loc'h C; Bendriem B; Crouzel C; Brouillet E; Maziere M
    J Cereb Blood Flow Metab; 1993 May; 13(3):454-68. PubMed ID: 8478404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [(11)C]Iomazenil in healthy human subjects.
    Bremner JD; Horti A; Staib LH; Zea-Ponce Y; Soufer R; Charney DS; Baldwin R
    Synapse; 2000 Jan; 35(1):68-77. PubMed ID: 10579810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.
    Millet P; Graf C; Buck A; Walder B; Ibáñez V
    Neuroimage; 2002 Oct; 17(2):928-42. PubMed ID: 12377167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolite analysis of [11C]flumazenil in human plasma: assessment as the standardized value for quantitative PET studies.
    Ishiwata K; Itou T; Ohyama M; Yamada T; Mishina M; Ishii K; Nariai T; Sasaki T; Oda K; Toyama H; Senda M
    Ann Nucl Med; 1998 Feb; 12(1):55-9. PubMed ID: 9559964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomography.
    Iyo M; Itoh T; Yamasaki T; Fukuda H; Inoue O; Shinotoh H; Suzuki K; Fukui S; Tateno Y
    Neuropharmacology; 1991 Mar; 30(3):207-15. PubMed ID: 1649414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy.
    Macdonald GA; Frey KA; Agranoff BW; Minoshima S; Koeppe RA; Kuhl DE; Shulkin BL; Lucey MR
    Hepatology; 1997 Aug; 26(2):277-82. PubMed ID: 9252134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodological aspects for in vitro characterization of receptor binding using 11C-labeled receptor ligands: a detailed study with the benzodiazepine receptor antagonist [11C]Ro 15-1788.
    Sihver W; Sihver S; Bergström M; Murata T; Matsumura K; Onoe H; Andersson Y; Bjurling P; Fasth KJ; Westerberg G; Ogren M; Jacobsson G; Lundqvist H; Oreland L; Watanabe Y; Långström B
    Nucl Med Biol; 1997 Nov; 24(8):723-31. PubMed ID: 9428597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
    Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
    Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-[11C]tracer single-acquisition positron emission tomography studies.
    Koeppe RA; Raffel DM; Snyder SE; Ficaro EP; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 2001 Dec; 21(12):1480-92. PubMed ID: 11740210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
    Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
    Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.
    Blomqvist G; Pauli S; Farde L; Eriksson L; Persson A; Halldin C
    Eur J Nucl Med; 1990; 16(4-6):257-65. PubMed ID: 2112470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Parametric images of central-type benzodiazepine receptor binding and ligand transport by two SPECT scans of 123I-iomazenil: relative quantification without blood data].
    Onishi Y; Yonekura Y; Tanaka F; Nishizawa S; Okazawa H; Ishizu K; Fujita T; Konishi J; Mukai T
    Kaku Igaku; 1996 Sep; 33(9):953-63. PubMed ID: 8921663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
    Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M
    Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model.
    Zhou Y; Endres CJ; Brasić JR; Huang SC; Wong DF
    Neuroimage; 2003 Apr; 18(4):975-89. PubMed ID: 12725772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.
    Moerlein SM; Perlmutter JS
    Eur J Pharmacol; 1992 Jul; 218(1):109-15. PubMed ID: 1327820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro receptor autoradiography of the human brain using an 11C-labelled benzodiazepine analogue.
    d'Argy R; Gillberg PG; Stålnacke CG; Persson A; Bergström M; Långström B; Schoeps KO; Aquilonius SM
    Neurosci Lett; 1988 Mar; 85(3):304-10. PubMed ID: 2834674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.
    Malizia AL; Cunningham VJ; Bell CJ; Liddle PF; Jones T; Nutt DJ
    Arch Gen Psychiatry; 1998 Aug; 55(8):715-20. PubMed ID: 9707382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [11C]flumazenil brain PET.
    Tsukamoto M; Katoh C; Shiga T; Kaji T; Kuge Y; Nakada K; Tamaki N
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):846-51. PubMed ID: 14985864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPECT quantification of benzodiazepine receptor concentration using a dual-ligand approach.
    Millet P; Graf C; Moulin M; Ibáñez V
    J Nucl Med; 2006 May; 47(5):783-92. PubMed ID: 16644748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of benzodiazepine receptors in human brain using the partial saturation method.
    Delforge J; Spelle L; Bendriem B; Samson Y; Bottlaender M; Papageorgiou S; Syrota A
    J Nucl Med; 1996 Jan; 37(1):5-11. PubMed ID: 8544001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.